3-(2'-pyridyldithio)benzyldiazoacetate has been researched along with roxarsone in 1 studies
| Studies (3-(2'-pyridyldithio)benzyldiazoacetate) | Trials (3-(2'-pyridyldithio)benzyldiazoacetate) | Recent Studies (post-2010) (3-(2'-pyridyldithio)benzyldiazoacetate) | Studies (roxarsone) | Trials (roxarsone) | Recent Studies (post-2010) (roxarsone) |
|---|---|---|---|---|---|
| 34 | 0 | 33 | 216 | 1 | 131 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, T; Kang, Z; Wang, A; Wang, K; Wang, T; Wei, H; Zhou, Q | 1 |
1 other study(ies) available for 3-(2'-pyridyldithio)benzyldiazoacetate and roxarsone
| Article | Year |
|---|---|
Roxarsone Delivery Nanocomposite Based on Nitrite-Functionalized Mesoporous Polydopamine for Multidrug-Resistant Bacterial Infections via Enhanced Chemo-Photothermal Therapy.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Mammals; Methicillin-Resistant Staphylococcus aureus; Nanocomposites; Nanoparticles; Nitrites; Photothermal Therapy; Roxarsone | 2023 |